<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">321356</article-id><article-id pub-id-type="doi">10.17816/KMJ321356</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Clinical experiences</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обмен клиническим опытом</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Immunocompetent cells of appendix in acute appendicitis in children with COVID-19</article-title><trans-title-group xml:lang="ru"><trans-title>Иммунокомпетентные клетки червеобразного отростка при остром аппендиците у детей с COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8447-2600</contrib-id><name-alternatives><name xml:lang="en"><surname>Demyashkin</surname><given-names>Grigory A.</given-names></name><name xml:lang="ru"><surname>Демяшкин</surname><given-names>Григорий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., Cand. Sci. (Med.); Head of Depart., Depart. of Pathomorphology, National Medical Research Radiological Centre; Head of the Depart., Depart. of Histology and Immunohistochemistry</p></bio><bio xml:lang="ru"><p>канд. мед. наук; зав. отделом патоморфологии, Национальный медицинский исследовательский центр радиологии; зав. лабораторией гистологии и иммуногистохимии</p></bio><email>dr.grigdem@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1344-3292</contrib-id><name-alternatives><name xml:lang="en"><surname>Gorokhov</surname><given-names>Konstantin R.</given-names></name><name xml:lang="ru"><surname>Горохов</surname><given-names>Константин Родионович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>M.D., Postgrad. Stud.; pathologist</p></bio><bio xml:lang="ru"><p>аспирант; врач-патологоанатом</p></bio><email>Gorohovko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-0493-2985</contrib-id><name-alternatives><name xml:lang="en"><surname>Pilipenko</surname><given-names>Alexandr A.</given-names></name><name xml:lang="ru"><surname>Пилипенко</surname><given-names>Александр Анатольевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student, Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>студент, Институт клинической медицины</p></bio><email>scientpapers4@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-0417-2743</contrib-id><name-alternatives><name xml:lang="en"><surname>Maslow</surname><given-names>Alexey V.</given-names></name><name xml:lang="ru"><surname>Маcлов</surname><given-names>Алексей Вадимович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student, Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>студент, Институт клинической медицины</p></bio><email>sambo-95@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3542-9723</contrib-id><name-alternatives><name xml:lang="en"><surname>Kochetkova</surname><given-names>Svetlana E.</given-names></name><name xml:lang="ru"><surname>Кочеткова</surname><given-names>Cветлана Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student, Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>студент, Институт клинической медицины</p></bio><email>sv.k0ch@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Medical Research Center for Radiology</institution></aff><aff><institution xml:lang="ru">Национальный медицинский исследовательский центр радиологии</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">First Moscow State Medical University named after I.M. Sechenov (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">First Moscow State Medical University named after I.M. Sechenov (Sechenov University)</institution></aff><aff><institution xml:lang="ru">Первый Московский государственный медицинский университет им. И.М. Сеченова
(Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-07-24" publication-format="electronic"><day>24</day><month>07</month><year>2023</year></pub-date><volume>104</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>623</fpage><lpage>629</lpage><history><date date-type="received" iso-8601-date="2023-03-14"><day>14</day><month>03</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-07-24"><day>24</day><month>07</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-Вектор</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-07-24"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/321356">https://kazanmedjournal.ru/kazanmedj/article/view/321356</self-uri><abstract xml:lang="en"><p><bold>Background.</bold> The study of the influence mechanisms of the SARS-CoV-2 virus on human homeostasis is still relevant. Of particular interest is the study of pathomorphological changes in the appendix in children with COVID-19 with the determination of the CD-phenotypic status of immunocompetent cells.</p> <p><bold>Aim.</bold> Immunohistochemical evaluation of appendix inflammation in children diagnosed with COVID-19.</p> <p><bold>Material and methods.</bold> The groups were formed on the basis of anamnestic, clinical and morphological data: the first group (n=42; age from 2 to 18 years, mean — 10.8±4.9 years) — surgical material of the vermiform processes of children with an established clinical diagnosis of “coronavirus infection” (COVID-19 based on PCR results); the second group (n=55; age from 2 to 18 years, mean — 9.7±4.2 years) — surgical material of the appendix after appendectomy in children with an established clinical diagnosis of “acute appendicitis” obtained before the onset of the COVID-19 pandemic; the third group (n=38; age from 2 to 18 years, mean — 10.3±3.2 years) — control group, autopsy material of appendixes (intact). Histological and immunohistochemical studies were carried out using primary antibodies to CD3, CD4, CD68, CD20, CD138. The number of CD+ cells was determined by computer morphometry in 10 fields of view. Student's t-test was used in quantitative analysis for a significant comparison between groups. Then, the quantitative density of CD+ cells per 1 mm2 was converted into a scoring system for visual presentation by a semi-quantitative method.</p> <p><bold>Results.</bold> Most samples (n=41) of the first group showed signs of destructive phlegmonous-ulcerative appendicitis. An immunohistochemical study revealed an increase in the number of T-lymphocytes (CD3+, CD4+), macrophages (CD68+), B-lymphocytes (CD20+) and plasma cells (CD138+) in the mucous membrane of the vermiform processes of children of the first group. In children of the second group, all clinical and morphological forms of acute appendicitis were found, the phenotype of immunocompetent cells corresponded to bacterial inflammation.</p> <p><bold>Conclusion.</bold> In children diagnosed with СOVID-19, confirmed by polymerase chain reaction, predominantly develop destructive forms of acute appendicitis, accompanied by microthrombosis and lymphocytic-plasmacytic infiltration with an increase in the number of immunocompetent cells CD3+, CD4+, CD68+, CD20+, CD138+.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность.</bold> Изучение механизмов влияния вируса SARS-CoV-2 на гомеостаз человека по-прежнему остаётся актуальным. Особый интерес вызывает исследование патоморфологических изменений червеобразного отростка у детей с COVID-19 c определением CD-фенотипического статуса иммунокомпетентных клеток.</p> <p><bold>Цель.</bold> Иммуногистохимическая оценка воспаления червеобразного отростка у детей с установленным диа¬гнозом COVID-19.</p> <p><bold>Материал и методы исследования.</bold> Группы были сформированы на основании анамнестических, клинических и морфологических данных: первая (n=42; возраст от 2 до 18 лет, средний — 10,8±4,9 года) — операционный материал червеобразных отростков детей с установленным клиническим диагнозом «коронавирусная инфекция» (COVID-19 по результатам полимеразной цепной реакции); вторая (n=55; возраст от 2 до 18 лет, средний — 9,7±4,2 года) — операционный материал червеобразных отростков после аппендэктомии у детей с установленным клиническим диагнозом «острый аппендицит», полученный до начала пандемии COVID-19; третья (n=38; возраст от 2 до 18 лет, средний — 10,3±3,2 года) — контрольная группа, аутопсийный материал червеобразных отростков (интактных). Проводили гистологическое и иммуногистохимическое исследования с использованием первичных антител к CD3, CD4, CD68, CD20, CD138. Количество CD+-клеток определяли при компьютерной морфометрии в 10 полях зрения. При количественном анализе использовали t-критерий Стьюдента для достоверного сравнения между группами. Затем количественную плотность CD+-клеток на 1 мм2 переводили в балльную систему для наглядного преставления полуколичественным методом.</p> <p><bold>Результаты.</bold> В большинстве образцов (n=41) первой группы выявлены признаки деструктивного флегмонозно-язвенного аппендицита. При иммуногистохимическом исследовании обнаружено увеличение количества Т-лимфоцитов (CD3+, CD4+), макрофагов (CD68+), В-лимфоцитов (CD20+) и плазмоцитов (CD138+) в слизистой оболочке червеобразных отростков детей первой группы. У детей второй группы были обнаружены все клинико-морфологические формы острого аппендицита, фенотип иммунокомпетентных клеток соответствовал бактериальному воспалению.</p> <p><bold>Вывод.</bold> У детей с диагнозом СOVID-19, подтверждённым при полимеразной цепной реакции, развиваются преимущественно деструктивные формы острого аппендицита, сопровождающегося микротромбозами и лимфоцитарно-плазмоцитарной инфильтрацией с увеличением количества иммунокомпетентных клеток CD3+, CD4+, CD68+, CD20+, CD138+.</p></trans-abstract><kwd-group xml:lang="en"><kwd>appendicitis</kwd><kwd>children</kwd><kwd>CD</kwd><kwd>COVID-19</kwd><kwd>immunohistochemistry</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аппендицит</kwd><kwd>дети</kwd><kwd>CD</kwd><kwd>COVID-19</kwd><kwd>иммуногистохимия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Robinson PC, Liew DFL, Tanner HL, Grainger JR, Dwek RA, Reisler RB, Steinman L, Feldmann M, Ho LP, Hussell T, Moss P, Richards D, Zitzmann N. COVID-19 therapeutics: Challenges and directions for the future. Proc Natl Acad Sci USA. 2022;119(15):e2119893119. DOI: 10.1073/pnas.2119893119.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365–388. DOI: 10.1080/10408363.2020.1783198.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, Bissett B, Boden IJ, Bradley S, Burrell A, Cooper DJ, Fulcher BJ, Haines KJ, Hopkins J, Jones AYM, Lane S, Lawrence D, van der Lee L, Liacos J, Linke NJ, Gomes LM, Nickels M, Ntoumenopoulos G, Myles PS, Patman S, Paton M, Pound G, Rai S, Rix A, Rollinson TC, Sivasuthan J, Tipping CJ, Thomas P, Trapani T, Udy AA, Whitehead C, Hodgson IT, Anderson S, Neto AS; COVID-Recovery Study Investigators and the ANZICS Clinical Trials Group. The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: A prospective cohort study. Crit Care. 2021;25(1):382. DOI: 10.1186/s13054-021-03794-0.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Heesakkers H, van der Hoeven JG, Corsten S, Janssen I, Ewalds E, Simons KS, Westerhof B, Rettig TCD, Jacobs C, van Santen S, Slooter AJC, van der Woude MCE, van den Boogaard M, Zegers M. Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19. JAMA. 2022;327(6):559–565. DOI: 10.1001/jama.2022.0040.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Dhochak N, Singhal T, Kabra SK, Lodha R. Pathophysiology of COVID-19: Why children fare better than adults? Indian J Pediatr. 2020;87(7):537–546. DOI: 10.1007/s12098-020-03322-y.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Nikolopoulou GB, Maltezou HC. COVID-19 in children: Where do we stand? Arch Med Res. 2022;53(1):1–8. DOI: 10.1016/j.arcmed.2021.07.002.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, Singh AR, Li S, Tarquinio KM, Jaggi P, Oster ME, Zackai SP, Gillen J, Ratner AJ, Walsh RF, Fitzgerald JC, Keenaghan MA, Alharash H, Doymaz S, Clouser KN, Giuliano JS Jr, Gupta A, Parker RM, Maddux AB, Havalad V, Ramsingh S, Bukulmez H, Bradford TT, Smith LS, Tenforde MW, Carroll CL, Riggs BJ, Gertz SJ, Daube A, Lansell A, Coronado Munoz A, Hobbs CV, Marohn KL, Halasa NB, Patel MM, Randolph AG; Overcoming COVID-19 Investigators; CDC COVID-19 Response Team. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334–346. DOI: 10.1056/NEJMoa2021680.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Giovanni JE, Hrapcak S, Melgar M, Godfred-Cato S. Global reports of intussusception in infants with SARS-CoV-2 infection. Pediatr Infect Dis J. 2021;40(1):35–36. DOI: 10.1097/INF.0000000000002946.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr. 2021;9:617980. DOI: 10.3389/fped.2021.617980.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50–54. DOI: 10.1126/science.abc1669.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Suwanwongse K, Shabarek N. Pseudo-appendicitis in an adolescent with COVID-19. Cureus. 2020;12(7):e9394. DOI: 10.7759/cureus.9394.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ahmad S, Ahmed RN, Jani P, Ullah M, Aboulgheit H. SARS-CoV-2 isolation from an appendix. J Surg Case Rep. 2020;(8):245. DOI: 10.1093/jscr/rjaa245.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Aljabr W, Al-Amari A, Abbas B, Karkashan A, Alamri S, Alnamnakani M, Al-Qahtani A. Evaluation of the levels of peripheral CD3+, CD4+, and CD8+ T cells and IgG and IgM antibodies in COVID-19 patients at different stages of infection. Microbiol Spectr. 2022;23;10(1):e0084521. DOI: 10.1128/spectrum.00845-21.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Anderson JE, Campbell JA, Durowoju L, Greenberg SLM, Rice-Townsend SE, Gow KW, Avansino J. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock. J Pediatr Surg Case Rep. 2021;71:101913. DOI: 10.1016/j.epsc.2021.101913.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Kind S, Merenkow C, Büscheck F, Möller K, Dum D, Chirico V, Luebke AM, Höflmayer D, Hinsch A, Jacobsen F, Göbel C, Weidemann S, Fraune C, Möller-Koop C, Hube-Magg C, Clauditz TS, Simon R, Sauter G, Wilczak W, Bawahab AA, Izbicki JR, Perez D, Marx A. Prevalence of Syndecan-1 (CD138) expression in different kinds of human tumors and normal tissues. Dis Markers. 2019;2019:4928315. DOI: 10.1155/2019/4928315.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hagen C, Nowack M, Messerli M, Saro F, Mangold F, Bode PK. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Swiss Med Wkly. 2021;151:w20557. DOI: 10.4414/smw.2021.20557.</mixed-citation></ref></ref-list></back></article>
